1.
Am J Cardiol
; 94(1): 92-5, 2004 Jul 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-15219514
RESUMO
Sixty-nine patients who underwent primary percutaneous coronary intervention within 12 hours after onset of acute myocardial infarction were randomized to receive intracoronary injection of autologous bone marrow mesenchymal stem cell or standard saline. Several imagining techniques demonstrated that bone marrow mesenchymal stem cells significantly improved left ventricular function.